HealthApr 23, 2026FDA approves Regeneron gene therapy to restore hearing for rare OTOF-related congenital deafnessThe U.S. Food and Drug Administration approved the first gene therapy intended to restore hearing for people born deaf due to mutations in the OTOF gene. The therapy...FDAGene therapyOTOF-related genetic deafness
HealthApr 22, 2026Study: Adeno-associated viral gene therapy restored hearing in most people with OTOF-related DFNB9; benefits persist more than two years for someA multinational research team led by investigators at Mass Eye and Ear and Fudan University reported results from a study of 42 children and adults (ages under 1 to ...Medical TechnologyGene therapyOTOF-related genetic deafness (DFNB9)